BIOCELL LTD
Company number 13949014 · Active · Gerrards Cross SL9 7QE
BIOCELL LTD is an active private limited company (company number 13949014) incorporated on 2 March 2022, registered in Gerrards Cross. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 December 2025, showing net assets of −£369k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 302% on the prior period (−£92k).
By net assets it sits in the bottom quarter of 50 comparable companies in Reading (median £11k, upper quartile £207k).
Key dates
- Incorporated
- 2 March 2022
- Next accounts due
- 30 September 2027 — in 343 days
- Confirmation statement due
- 16 March 2027 — in 145 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 December 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£369k | — | — | £419k | — | — | 2 |
| 31 December 2024 | −£92k | — | — | £132k | — | — | 2 |
- Current ratio
- 0.12 — current liabilities exceed current assets
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 23/100 (grade E)
- -15 Negative net assets — Net assets £-369,258 at 2025-12-31
- -8 Net assets falling — -302.0% vs prior period
- -8 Current liabilities exceed current assets — Current ratio 0.12
- +4 Past first filings — Incorporated 2022-03-02
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Victor Kevehazi — owns 25–50% of shares; holds 25–50% of voting rights · since 2 March 2022
- Mrs Laura Mann Kevehazi — owns 50–75% of shares; holds 50–75% of voting rights; can appoint or remove directors · since 2 March 2022
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Reading
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- ELIPTICA LIMITED — Newbury, inc. Apr 2022
- ALKINDI MEDICAL LTD — Maidenhead, inc. Oct 2021
- REPLAY BIOTECHNOLOGY UK LIMITED — Reading, inc. Sept 2021
- EXCELYA CLINICAL RESEARCH LIMITED — Newbury, inc. Jul 2021
- BLOC GEL LTD — Reading, inc. Feb 2021
- GROVE BIO CONSULTING LTD — Slough, inc. Feb 2021
All companies incorporated on 2 March 2022 · in Mar 2022.
Reminders for BIOCELL LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.